comparemela.com

Latest Breaking News On - Eversana - Page 3 : comparemela.com

INVESTOR ALERT: Kaplan Fox Investigates Mersana

NEW YORK, June 19, 2023 (GLOBE NEWSWIRE) Kaplan Fox & Kilsheimer LLP (www.kaplanfox.com) is investigating potential claims on behalf of investors.

United statesNew yorkNew jerseyLos angelesKaplan foxJeffreyp campisiLaurenced kingMersana therapeutics incDrug administrationKaplan fox kilsheimerMersana therapeuticsKaplan fox amp kilsheimer llpMersana therapeuticsRsn newsKaplan foxClinical trial

5 deaths partially halt drug trial

Two Cambridge, Mass.-based pharma companies have paused cancer drug trials after six patients died. Investigations are underway.

United kingdomMersana therapeuticUp nextPgrade aPatient safetyPatient death

EVERSANA INTOUCH Wins Five Clio Awards

/PRNewswire/ EVERSANA, a leading provider of commercial services to the global life sciences industry, today announced that its agency network, EVERSANA.

United statesMatt braunJim langHome health awareness advocacyHome craft health awareness advocacyStage prototype innovation health awareness advocacyCorporate communicationsChrysalis initiativeActivation health awareness advocacyGlobal lyme allianceClio healthCreative use of data health awareness advocacyGlobal lymeClio awardsHome craftHealth awareness

EVERSANA Forms Strategic Alliance with China Resource Pharmaceutical Commercial Group to Bring New Novel Treatments to Patients Globally

/PRNewswire/ EVERSANA®, a leading provider of commercialization services to the global life sciences industry, today announced that it has established a.

Jim langMatt braunFranko guoChina resources pharmaceutical commercial groupChina resources pharmaceutical commercial group co ltdChina resources pharmaceutical groupChina resource pharmaceutical commercial groupCorporate communicationsChina resource pharma commVice presidentChina resource pharmaceutical commercialChina resources pharmaceuticalChina resourcesResource pharma comm

Renalytix picks Eversana to commercialise prognostic device

Renalytix PLC - London-based kidney health-focused diagnostics company - Announces partnership with life-science commercialisation company Eversana Life Science Services LLC. Will expand commercial. | May 25, 2023

City ofUnited kingdomNew yorkUnited statesEmma curzonJames mcculloughEversana life science servicesAmerican diabetes associationAlliance newsAlliance news ltdChief executive officer james mcculloughAll rightsRenalytix plc stock exchangePress releaseXpand renx gb00bywl4y04

vimarsana © 2020. All Rights Reserved.